Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

BACKGROUND: Data concerning the impact of hepatitis C virus (HCV) cure on type 2 diabetes mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti‐HCV direct‐acting antiviral (DAA) treatments on long‐term glucose control in HCV/T2DM patients with chronic hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciola, Irene, Russo, Giuseppina, Filomia, Roberto, Pitrone, Concetta, Caccamo, Gaia, Giandalia, Annalisa, Alibrandi, Angela, Stella Franzè, Maria, Porcari, Serena, Maimone, Sergio, Saitta, Carlo, Squadrito, Giovanni, Raimondo, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506140/
https://www.ncbi.nlm.nih.gov/pubmed/33894103
http://dx.doi.org/10.1111/liv.14905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506140/
https://www.ncbi.nlm.nih.gov/pubmed/33894103
http://dx.doi.org/10.1111/liv.14905

Ejemplares similares